Tracking in situ checkpoint inhibitor-bound target T cells in patients with checkpoint-induced colitis
Gupta T. et al, (2024), Cancer Cell, 42, 797 - 814.e15
Interferon-Gamma–Producing CD8+ Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor–Colitis
Sasson SC. et al, (2021), Gastroenterology, 161, 1229 - 1244.e9
Spatiotemporal analysis of human intestinal development at single-cell resolution
Fawkner-Corbett D. et al, (2021), Cell, 184, 810 - 826.e23
Single-cell atlas of colonic CD8+ T cells in ulcerative colitis
Corridoni D. et al, (2020), Nature Medicine, 26, 1480 - 1490
Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?
Cheung VTF. et al, (2020), British Journal of Cancer, 123, 207 - 215
Aortic valve area using computed tomography‐derived correction factor to improve the validity of left ventricular outflow tract measurements
Alskaf E. et al, (2020), Echocardiography, 37, 196 - 206
Immune checkpoint inhibitor-related colitis assessment and prognosis: can inflammatory bowel disease scoring point the way?
Cheung VTF. et al, (2020), JOURNAL OF CROHNS & COLITIS, 14, S286 - S288
Immunotherapy-related hepatitis: real-world experience from a tertiary centre
Cheung V. et al, (2019), Frontline Gastroenterology, 10, 364 - 371
IMMUNOTHERAPY-RELATED GASTRITIS IN A TERTIARY ONCOLOGY CENTRE
Cheung V. et al, (2019), GUT, 68, A147 - A148
Immunotherapy-related hepatitis: real-world experience from a tertiary centre
CHEUNG VINCENT. et al, (2019), Frontline Gastroenterology
Real-world data: the incidence, diagnosis, and management outcomes of patients with immunotherapy-related colitis in two tertiary centres
Cheung V. et al, (2019), JOURNAL OF CROHNS & COLITIS, 13, S137 - S138
Tissue-based activation of mucosal-associated invariant T (MAIT) cells in combination ipilimumab and nivolumab checkpoint inhibitor (CI) colitis
Sasson SC. et al, (2019), ANNALS OF ONCOLOGY, 30, 530 - 530